엑소좀 치료제 시장은 2023-2028년간 2억 3,470만 달러 확대되고, 예측 기간 동안 16.19%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
본 보고서에서는 엑소좀 치료제 시장의 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등을 정리하여 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 만성 질환의 유병률 증가, 개인 맞춤형 의료에서 엑솜의 잠재력, 엑솜 치료제에 대한 연구 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준년도 |
2024년 |
| 종료년도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 2024년 전년 대비 |
15.76% |
| CAGR |
16.19% |
| 증분 금액 |
2억 3,470만 달러 |
이 보고서는 엑소좀 수집의 첨단 기술이 향후 몇 년동안 엑소좀 치료제 시장의 성장을 가속하는 주요 이유 중 하나로 꼽았습니다. 또한, 공급업체와 의료 기관과의 파트너십 및 공동 연구 증가, 번역 나노 의약품을 위한 인공 엑소좀은 시장의 큰 수요로 이어질 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채택 비율·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2023년)
- 시장 전망(2023-2028년)
제5장 시장 규모 실적
- 세계의 엑소좀 치료제 시장(2018-2022년)
- 용도별 부문 분석(2018-2022년)
- 유통 채널별 부문 분석(2018-2022년)
- 지역별 부문 분석(2018-2022년)
- 국가별 부문 분석(2018-2022년)
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 용도별
- 시장 세분화
- 비교 : 용도별
- 암치료 : 시장 규모와 예측(2023-2028년)
- 자가면역질환 : 시장 규모와 예측(2023-2028년)
- 감염증 : 시장 규모와 예측(2023-2028년)
- 기타 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 용도별
제9장 시장 세분화 : 유통 채널별
- 시장 세분화
- 비교 : 유통 채널별
- 병원 약국 : 시장 규모와 예측(2023-2028년)
- 소매 약국 : 시장 규모와 예측(2023-2028년)
- 온라인 약국 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 유통 채널별
제10장 고객 상황
제11장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2023-2028년)
- 유럽 : 시장 규모와 예측(2023-2028년)
- 아시아 : 시장 규모와 예측(2023-2028년)
- 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
- 미국 : 시장 규모와 예측(2023-2028년)
- 독일 : 시장 규모와 예측(2023-2028년)
- 영국 : 시장 규모와 예측(2023-2028년)
- 중국 : 시장 규모와 예측(2023-2028년)
- 일본 : 시장 규모와 예측(2023-2028년)
- 캐나다 : 시장 규모와 예측(2023-2028년)
- 프랑스 : 시장 규모와 예측(2023-2028년)
- 이탈리아 : 시장 규모와 예측(2023-2028년)
- 덴마크 : 시장 규모와 예측(2023-2028년)
- 인도 : 시장 규모와 예측(2023-2028년)
- 시장 기회 : 지역 상황별
제12장 성장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회, 성장 억제요인
제13장 경쟁 구도
제14장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Aegle Therapeutics
- Aethlon Medical Inc.
- AMS Biotechnology Europe Ltd.
- Capital Biosciences Inc.
- Capricor Therapeutics Inc.
- CILOA SAS
- Creative Biolabs
- Cytiva
- Everzom
- Evotec SE
- Evox Therapeutics Ltd.
- Inoviq Ltd.
- NanoFCM Co., Ltd
- The ExoBiologics Co.
- Thermo Fisher Scientific Inc.
제15장 부록
LSH
The exosome therapeutics market is forecasted to grow by USD 234.7 mn during 2023-2028, accelerating at a CAGR of 16.19% during the forecast period. The report on the exosome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, potential of exosomes in personalized medicine, and rising research on exosome therapeutics.
Technavio's exosome therapeutics market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 15.76% |
| CAGR | 16.19% |
| Incremental Value | $234.7 mn |
By Application
- Cancer therapies
- Autoimmune diseases
- Infectious diseases
- Others
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advanced technology in exosome collection as one of the prime reasons driving the exosome therapeutics market growth during the next few years. Also, rising partnerships and collaborations between vendors and healthcare organisations and artificial exosomes for translational nanomedicine will lead to sizable demand in the market.
The report on the exosome therapeutics market covers the following areas:
- Exosome therapeutics market sizing
- Exosome therapeutics market forecast
- Exosome therapeutics market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome therapeutics market vendors that include Aegle Therapeutics, Aethlon Medical Inc., AMS Biotechnology Europe Ltd., Bio Techne Corp., Capital Biosciences Inc., Capricor Therapeutics Inc., CILOA SAS, Creative Biolabs, Cytiva, Everzom, Evotec SE, Evox Therapeutics Ltd., ExoCoBio Co. Ltd., Inoviq Ltd., Lonza Group Ltd., NanoFCM Co., Ltd, Regeneron Pharmaceuticals Inc., ReNeuron Group PLC, The ExoBiologics Co., and Thermo Fisher Scientific Inc.. Also, the exosome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2023
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Exosome Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Exosome Therapeutics Market 2018 - 2022 ($ million)
- 5.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
- 5.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
- 5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI in the Global Exosome Therapeutics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Application
- 8.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 8.3 Cancer therapies - Market size and forecast 2023-2028
- Chart on Cancer therapies - Market size and forecast 2023-2028 ($ million)
- Data Table on Cancer therapies - Market size and forecast 2023-2028 ($ million)
- Chart on Cancer therapies - Year-over-year growth 2023-2028 (%)
- Data Table on Cancer therapies - Year-over-year growth 2023-2028 (%)
- 8.4 Autoimmune diseases - Market size and forecast 2023-2028
- Chart on Autoimmune diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Autoimmune diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Autoimmune diseases - Year-over-year growth 2023-2028 (%)
- 8.5 Infectious diseases - Market size and forecast 2023-2028
- Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
- 8.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
- 9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 9.3 Hospital pharmacy - Market size and forecast 2023-2028
- Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- 9.4 Retail pharmacy - Market size and forecast 2023-2028
- Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- 9.5 Online pharmacy - Market size and forecast 2023-2028
- Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
- 9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.12 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 11.13 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 11.14 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
- 11.15 Denmark - Market size and forecast 2023-2028
- Chart on Denmark - Market size and forecast 2023-2028 ($ million)
- Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
- Chart on Denmark - Year-over-year growth 2023-2028 (%)
- Data Table on Denmark - Year-over-year growth 2023-2028 (%)
- 11.16 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.1 Market drivers
- 12.2 Market challenges
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Aegle Therapeutics
- Aegle Therapeutics - Overview
- Aegle Therapeutics - Product / Service
- Aegle Therapeutics - Key offerings
- SWOT
- 14.5 Aethlon Medical Inc.
- Aethlon Medical Inc. - Overview
- Aethlon Medical Inc. - Product / Service
- Aethlon Medical Inc. - Key offerings
- SWOT
- 14.6 AMS Biotechnology Europe Ltd.
- AMS Biotechnology Europe Ltd. - Overview
- AMS Biotechnology Europe Ltd. - Product / Service
- AMS Biotechnology Europe Ltd. - Key offerings
- SWOT
- 14.7 Capital Biosciences Inc.
- Capital Biosciences Inc. - Overview
- Capital Biosciences Inc. - Product / Service
- Capital Biosciences Inc. - Key offerings
- SWOT
- 14.8 Capricor Therapeutics Inc.
- Capricor Therapeutics Inc. - Overview
- Capricor Therapeutics Inc. - Product / Service
- Capricor Therapeutics Inc. - Key offerings
- SWOT
- 14.9 CILOA SAS
- CILOA SAS - Overview
- CILOA SAS - Product / Service
- CILOA SAS - Key offerings
- SWOT
- 14.10 Creative Biolabs
- Creative Biolabs - Overview
- Creative Biolabs - Product / Service
- Creative Biolabs - Key offerings
- SWOT
- 14.11 Cytiva
- Cytiva - Overview
- Cytiva - Product / Service
- Cytiva - Key offerings
- SWOT
- 14.12 Everzom
- Everzom - Overview
- Everzom - Product / Service
- Everzom - Key offerings
- SWOT
- 14.13 Evotec SE
- Evotec SE - Overview
- Evotec SE - Business segments
- Evotec SE - Key news
- Evotec SE - Key offerings
- Evotec SE - Segment focus
- SWOT
- 14.14 Evox Therapeutics Ltd.
- Evox Therapeutics Ltd. - Overview
- Evox Therapeutics Ltd. - Product / Service
- Evox Therapeutics Ltd. - Key offerings
- SWOT
- 14.15 Inoviq Ltd.
- Inoviq Ltd. - Overview
- Inoviq Ltd. - Product / Service
- Inoviq Ltd. - Key offerings
- SWOT
- 14.16 NanoFCM Co., Ltd
- NanoFCM Co., Ltd - Overview
- NanoFCM Co., Ltd - Product / Service
- NanoFCM Co., Ltd - Key offerings
- SWOT
- 14.17 The ExoBiologics Co.
- The ExoBiologics Co. - Overview
- The ExoBiologics Co. - Product / Service
- The ExoBiologics Co. - Key offerings
- SWOT
- 14.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15 Appendix
- 15.1 Scope of the report
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
